Epinastine Hydrochloride

盐酸依匹斯汀

Report date: 2026/04/06 20:01:48
NME

Base Information

Drug NameEpinastine Hydrochloride
Drug Alias Name依匹斯汀盐酸盐Purivist盐酸依批斯丁EpinastinumEpinastina +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsUrticariaPsoriasisPruritus +[12] 
Global Approved IndicationsUrticariaPsoriasisPruritus +[9] 
Approved Indications in ChinaUrticariaPsoriasisPruritus +[8] 
Original Approved Country/TerritoryMainland China
Original Approved Date2000/06/16
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesNippon Boehringer Ingelheim Co LtdTatsumi Kagaku Co LtdSanten Pharmaceutical Co Ltd +[6] 
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgAllergan IncMerck Sharp & Dohme LLC
Active IndicationsUrticariaPsoriasisPruritus +[9] 
Inactive IndicationsDermatitis, AtopicRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Other Information

ATC CodeR06AX24S01GX10
Related LinksWikipediaDrugBankKEGG